您好,欢迎来到上海士研管理咨询有限公司
士研峰会 士研智库 士研调研
嘉宾信息
 沈宏
沈宏
所属职位: 负责人,罗氏上海创新中心
所属公司:

罗氏上海创新中心

沈宏博士本科毕业于北京大学,在斯坦福大学获化学博士。在美国默沙东公司工作9年后,2012年沈宏博士加盟罗氏上海创新中心,现任研发中心负责人。现在沈宏博士主要参与免疫,肿瘤,抗感染疾病领域的药物研发,并曾经在动脉血管硬化症,高血压,糖尿病,血栓,肥胖症以及神经系统领域从事药物研究。他所在的团队为12个临床化合物做出了重要贡献。沈宏博士参于著书3部,发表学术论文逾百篇,为80多项药物发现专利的共同发明人,作过上百次学术报告。沈宏博士是英国皇家化学学会会士,担任多种科学杂志,书籍,和学术会议的科学专家顾问或评委。 Dr. Hong Shen received his B.S. from Peking University and Ph.D. in chemistry from Stanford University. After 9 years working at Merck in the US, he joined Roche Innovation Center Shanghai (RICS) in 2012. He is now the Site Head of RICS. Dr. Shen’s currently mainly focuses on drug discovery and development in the areas of immunology, oncology, and infectious diseases, and he once participated in drug discovery in atherosclerosis, hypertension, diabetes, thrombosis, obesity, and CNS areas. His teams have made significant contributions to 12 clinical compounds. Dr. Shen has contributed to 3 books, more than 100 publications, and over 80 patent applications. He has delivered over 100 invited lectures. Dr. Shen is a Fellow of the Royal Society of Chemistry (FRSC), a reviewer of numerous international journals, and a scientific advisor of 3 journals/book series.  

微信公众号
领导者网络APP
友情链接
Copyright ©2005 - 2017上海士研管理咨询有限公司
犀牛云提供企业云服务